TGen and ASU researchers find drug that could reduce risk of Alzheimer’s

(The Translational Genomics Research Institute) A used to improve blood flow to the also could help improve learning and memory and reduce the risk of Alzheimer’s disease, according to a new study released today by investigators at the Translational Genomics Research Institute (TGen) and Arizona State University.


Read more

Related posts

Leave a Reply